MELINTA THERAPEUTICS INC's ticker is MLNTXXXX and the CUSIP is 58549G100. A total of 79 filers reported holding MELINTA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $476,000 | -84.0% | 600,185 | -20.4% | 0.00% | -75.0% |
| Q3 2018 | $2,980,000 | -59.6% | 754,336 | -35.1% | 0.00% | -60.0% |
| Q2 2018 | $7,378,000 | +123.2% | 1,161,861 | +160.1% | 0.01% | +150.0% |
| Q1 2018 | $3,306,000 | -25.0% | 446,713 | +60.2% | 0.00% | -33.3% |
| Q4 2017 | $4,407,000 | – | 278,915 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISTHMUS PARTNERS, LLC | 84,072 | $7,657,000 | 1.86% |
| Sterling Investment Advisors, Ltd. | 19 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |